Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Front Biosci (Landmark Ed) ; 29(3): 124, 2024 Mar 22.
Artículo en Inglés | MEDLINE | ID: mdl-38538283

RESUMEN

BACKGROUND: Toxocara canis (T. canis) is a helminth parasite of zoonotic and veterinary health significance that causes the disease known as Toxocariasis. This disease has been associated with conditions of poverty, especially in tropical climate zones throughout the world. Although it rarely causes important clinical manifestations, T. canis can lead to blindness, meningoencephalitis, or other nervous manifestations in humans. Moreover, some studies show its importance in the development of tumor growth, which have been associated with the parasite's ability to modulate the host's immune response. While different studies have evaluated the immune response during this disease, currently, there are no studies where the infection is analyzed from the perspective of sexual dimorphism. METHODS: To evaluate sex differences in susceptibility, we analyzed lesions and parasite loads in lung and liver at 7 days post-infection. In addition, immune cell subpopulations were analyzed in spleen, mesenteric and peripheral lymph nodes. Finally, the production of cytokines and specific antibodies were determined in the serum. Statical analyses were performed using a Two-way ANOVA and a post-hoc Bonferroni multiple comparison test. RESULTS: Female rats had a higher number of larvae in the liver, while male rats had them in the lungs. The percentages of immune cells were evaluated, and in most cases, no significant differences were observed. Regarding the cytokines production, infection can generate a decrease in Th1 such as IL-1ß in both sexes and IL-6 only in females. In the case of Th2, IL-4 increases only in infected males and IL-5 increases in males while decreasing in females due to the effect of infection. IL-10 also decreases in both sexes as a consequence of the infection, and TGF-ß only in females. Finally, the infection generates the production of antibodies against the parasite, however, their quantity is lower in females. CONCLUSIONS: This study demonstrates that T. canis infection is dimorphic and affects females more than males. This is due to a polarization of the inadequate immune response, which is reflected as a higher parasite load in this sex.


Asunto(s)
Toxocara canis , Toxocariasis , Humanos , Femenino , Ratas , Masculino , Animales , Toxocariasis/parasitología , Toxocariasis/patología , Toxocara canis/fisiología , Caracteres Sexuales , Citocinas , Inmunidad
2.
Mol Biochem Parasitol ; 253: 111545, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-36681328

RESUMEN

The aim of this study was to evaluate the in vitro immune modulation of two de novo peptides with hypothetical identity to the serine protease family (S28) from Haemonchus spp. Expression of mRNAs encoding these peptides was confirmed by RTqPCR in L3 and adult stage parasites. Antibodies from serum samples collected from an H. contortus-infected lamb at 60 days post infection detected both peptides, as assessed by indirect ELISA. Lamb peripheral blood mononuclear cells (PBMCs) were exposed to each peptide, as well as to the peptide mixture, and cell proliferation assays were performed at 24, 48 and 72 h. The relative expression of the IL4, IL5, IL6, IL13, CXCL8 and FCεR1A genes was quantified by RTqPCR from lamb PBMCs exposed to the peptide mixture at 24 and 48 h. With respect to immune gene expression, 15- and 3-fold upregulation at 24 h was observed with IL5 and CXCL8, respectively, and 2-fold upregulation of CXCL8 at 48 h. In contrast, downregulation of IL5 was stimulated at 48 h. These data suggest that these peptides (pep-hsp and pep-pcx), which show high identity with intestinal and excretion/secretion serine proteases, can trigger immunogenic activity, and suggest that they may be useful as potential parasite vaccines.


Asunto(s)
Hemoncosis , Haemonchus , Animales , Ovinos , Leucocitos Mononucleares/metabolismo , Serina Proteasas/genética , Serina Proteasas/metabolismo , Haemonchus/genética , Interleucina-5/genética , Interleucina-5/metabolismo , Regulación hacia Arriba , Hemoncosis/veterinaria , Hemoncosis/metabolismo
3.
J Vis Exp ; (202)2023 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-38163274

RESUMEN

Diagnosis of canine parasites with zoonotic potential such as Toxocara canis and Ancylostoma caninum under field conditions is usually difficult due to limited access to a laboratory in rural and suburban areas in Mexico. This study aimed to detect T. canis and Ancylostoma spp. in fecal samples collected from dogs in Mexico from 2017 to 2021 under field conditions. Sample size calculation resulted in a target enrollment of 534 dogs across the country. Samples were collected directly from the rectum or the ground after defecation. Samples were stored in individual, tightly sealed, plastic bags at 4 °C. A saturated solution of sodium chloride (specific gravity [SpG] 1.20) was prepared both under field and laboratory conditions. Within 3 days of collection, 2-4 g of feces were tested for parasites using a flotation method by suspending each fecal sample in a saline solution. Feces were mixed with the flotation solution and crushed using a metal spoon. Once a uniform consistency was achieved, the fecal sample was poured into a new plastic cup using a sieve and allowed to sit for 10-15 min. Three drops from the top of the mixture were collected using a sterilized inoculating loop. The slides were placed on the microscope and parasites were identified by trained parasitologists. Fecal samples from 1,055 dogs were screened microscopically. The number of positive samples for Ancylostoma spp. was 833 (78.95% frequency) and 222 (21.04%) for T. canis. These findings illustrate the importance of identifying zoonotic helminths in dogs living in urban and rural areas in Mexico using a coproparasitoscopic technique in the laboratory and under field conditions.


Asunto(s)
Enfermedades de los Perros , Parásitos , Toxocara canis , Animales , Perros , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/parasitología , Ancylostoma , Heces
4.
J Equine Vet Sci ; 116: 104049, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35716836

RESUMEN

The present study was conducted to investigate the aqueous extracts of Azadirachta indica (AZN), Cnidoscolus angustidens (CNA), and their combination (MIX) at dosages of 0-, 0.6-, 1.2-, and 1.8- mL for their ability to reduce greenhouse gases and fermentation profiles in an in vitro study using horse feces and a nutrient-dense diet (as substrate). The quantity of greenhouse gas and fermentation profiles were determined in in vitro incubation for 48 h. Extracts of AZN, CNA, and MIX reduced total gas production of the incubated and degraded substrates in a dose-dependent and time-dependent manner. Production of CH4 was reduced (P < .05) by 4.41% to 54.54% with the incubated substrates and by 1.16% to 61.82% with the degraded substrates. However, AZN and MIX reduced (P < .05) CO by 4.43% to 12.85% with the incubated substrates and by 0.70% to 16.78% with the degraded substrates. In like manner, the plant extracts and combination reduced (P < .05) H2S production in a dose-dependent and time-dependent manner by 18.37% to 67.35% with the incubated substrates and by 8.51% to 67.23% with the degraded substrates. Extracts maintained pH within the normal range, reduced dry matter digestibility and metabolizable energy, and improved (P < .05) concentration of short chain fatty acids. Overall, aqueous extracts of AZN and CNA and their combinations had a positive effect on reducing the greenhouse gas production with no deleterious effect on fecal horses' fermentation activities.


Asunto(s)
Azadirachta , Euphorbiaceae , Gases de Efecto Invernadero , Animales , Azadirachta/metabolismo , Dieta/veterinaria , Euphorbiaceae/metabolismo , Heces , Gases de Efecto Invernadero/metabolismo , Caballos , Rumen
5.
J Equine Vet Sci ; 113: 103938, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35346771

RESUMEN

Greenhouse gases emission from livestock is the major concern for the ecosystem. Despite the lower contribution of non-ruminants towards greenhouse gas emission as compared to the ruminants, the emission of methane (CH4) gas from equines is expected to be increased in future due to its increasing population. Thus, it is essential to find or screen potential anti-methanogenic agent in a cost-effective and quicker manner. Considering this, the present investigation was aimed to analyze anti-methanogenic characteristic of bioactive compounds of safflower oil by targeting methanogenesis catalyzing enzyme (Methyl-coenzyme M reductase; MCR) via in silico tool. Initially, a total of 25 compounds associated with safflower oil were selected and their drug-likeness traits were predicted through Lipinski's rule of 5. Of 25 compounds, 9 compounds passed all the parameters of Lipinski's rule of five. These 9 ligands were further submitted for ADME traits analysis using Swiss ADME tool. Results revealed the absence of Lipinski's violation and approval of drug-likeness attributes of methyl tetradecanoate, 3-isopropyl-6-methylenecyclohex-1-ene, trans-2,4-decadienal, cis-6-nonenal, limonene, syringic acids, matairesinol, acacetin, and 2,5-octanedione. Molecular docking analysis was performed for analyzing the affinity between the selected 9 ligands and MCR receptor using FRED v3.2.0 from OpenEye Scientific Software and Discovery Studio client v16.1.0. Results showed maximum binding interaction of acacetin with MCR with the chemguass4 score of -13.35. Other ligands showed comparatively lower binding affinity in the order of matairesinol (-12.43) > methyl tetradecanoate (-9.25) > cis-6-nonenal (-7.88) > syringic acids (-7.73) > limonene (-7.18) > trans-2,4-decadienal (-7.07) > 3-isopropyl-6-methylenecyclohex-1-ene (-7.01) > 2,5-octanedione (-7.0.). In a nutshell, these identified compounds were observed as potential agents to reduce CH4 production from equines by targeting MCR. This in silico study emphasized the role of safflower-associated compounds in developing anti-methanogenic drug for equines in future.


Asunto(s)
Euryarchaeota , Gases de Efecto Invernadero , Animales , Ecosistema , Euryarchaeota/metabolismo , Gases de Efecto Invernadero/metabolismo , Caballos , Ligandos , Limoneno/metabolismo , Simulación del Acoplamiento Molecular , Oxidorreductasas , Aceite de Cártamo/metabolismo
6.
J Equine Vet Sci ; 110: 103863, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-35017039

RESUMEN

Oxidative stress is the excess generation of free radicals and/or a decrease in the response of the antioxidant system. It is known to cause damage to the equine health by unbalancing the stable molecules. The dietary supplementation of vitamins E, C, and ß-carotene cause beneficial effect on horses' health. These supplements could transform free radicals into the stable radicals, thereby showing importance in the prevention of diseases associated with oxidative stress. Adding vitamins E, C, and ß-carotene to the horses' diets in stressful conditions could decrease the production of free radicals that cause inflammation and tissue damage, the typical characteristics that have been associated with oxidative stress. This review spotlights the available evidence of the benefits of dietary supplements of vitamins E, C, and ß-carotene towards the reduction of oxidative stress in horses.


Asunto(s)
Vitamina E , beta Caroteno , Animales , Ácido Ascórbico , Suplementos Dietéticos , Caballos , Estrés Oxidativo , Vitamina E/farmacología , Vitaminas/farmacología , beta Caroteno/farmacología
7.
Parasitol Int ; 83: 102355, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33872793

RESUMEN

Fascioliasis is a worldwide emergent zoonotic disease that significantly constrains the productivity of livestock. In this study, fluke burdens, liver fluke size and biomass, faecal eggs counts, serum levels of hepatic enzymes and immune response were assessed in sheep vaccinated with peptide mimotopes of cathepsin L and infected with metacercariae. A total of 25 sheep were allocated randomly into five groups of five animals each, and experimental groups were immunised with 1 × 1013 filamentous phage particles of cathepsin L1 (CL1) (TPWKDKQ), CL2 (YGSCFLR) and mixtures of CL1 + CL2 mimotopes, in combination with Quil A adjuvant, and wild-type M13KE phage in a two-vaccination scheme on weeks 0 and 4. The control group received phosphate-buffered saline. All groups were challenged with 300 metacercariae two weeks after the last immunisation and euthanised 16 weeks later. The CL1 vaccine was estimated to provide 57.58% protection compared with the control group; no effect was observed in animals immunised with CL2 and CL1 + CL2 (33.14% and 11.63%, respectively). However, animals receiving CL2 had a significant reduction in parasite egg output. Vaccinated animals showed a significant reduction in fluke length and width and wet weights. In the CL1 group, there was a significant reduction in the total biomass of parasites recovered. Egg development was divided into seven stages: dead, empty, unembryonated, cell division, eyespot, hatched and hatching. The highest percentage of developmental stages was detected for vaccinated sheep administered CL1 + CL2 with cell division, and the lowest percentage was observed in the hatching stage. Furthermore, a significant difference in all developmental stages was observed between vaccinated animals and the control group (P < 0.01). The levels of anti-phage total IgG in immune sera increased significantly at four weeks after immunisation and were always significantly higher for cathepsin L vaccine group than in the challenged control group. Total IgG was inversely and significantly correlated with worm burden in the CL1 group.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Catepsina L/inmunología , Fasciola hepatica/inmunología , Fascioliasis/veterinaria , Enfermedades de las Ovejas/prevención & control , Vacunación/veterinaria , Vacunas/administración & dosificación , Animales , Bacteriófagos , Fascioliasis/parasitología , Fascioliasis/prevención & control , Masculino , Dinámica Poblacional , Reproducción , Ovinos , Enfermedades de las Ovejas/parasitología , Oveja Doméstica
8.
Microb Pathog ; 155: 104859, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33845124

RESUMEN

Fasciolosis is a worldwide emergent zoonotic disease that significantly constrains the productivity of livestock. We conducted an experimental trial with four groups of five goats each, vaccinated with 1 × 1013 phage particles of cathepsin L1 (CLI: DPWWLKQ), CL1 (SGTFLFS), and CL2 (PPIRNGK) mimotopes combined with Quil A adjuvant. Animals received a booster four weeks later. The control group received phosphate-buffered saline. All animals were infected with 200 Fasciola hepatica metacercariae at week six and euthanised 16 weeks later. The percentage of significant worm reduction in CL1 (DPWWLKQ), CL1 (SGTFLFS), and CL2 (PPIRNGK) compared to the control group were 55.40%, 70.42% (P < 0.05), and 32.39%, respectively. Vaccinated animals showed a significant reduction in faecal egg production and egg viability. A significant reduction in the total biomass of parasites recovered was observed in the CL1 (DPWWLKQ) and CL1 (SGTFLFS) groups. In goats vaccinated with CL2 (PPIRNGK), fluke length and width were smaller than those in the control group. Furthermore, animals receiving CL mimotopes showed a significant reduction in the total area of reproductive structures. Goats immunised with phage-displayed mimotopes produced significantly high titres of specific IgG1 and IgG2 isotypes, indicating a mixed Th1/Th2 response. The liver fluke burdens in goats vaccinated with CL1 (DPWWLKQ) and CL1 (SGTFLFS) were significantly correlated with IgG and IgG1 levels.


Asunto(s)
Fasciola hepatica , Fascioliasis/veterinaria , Enfermedades de las Cabras/prevención & control , Vacunación , Animales , Anticuerpos Antihelmínticos/sangre , Catepsina L , Fasciola hepatica/inmunología , Fascioliasis/prevención & control , Cabras
9.
Parasitol Res ; 119(3): 1057-1074, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31901110

RESUMEN

Ruminant coccidiosis is a gastrointestinal disease caused by parasites of the genus Eimeria. Environmental and climatic factors are relevant for the development, survival, and transmission of coccidiosis because Eimeria oocysts are able to survive in the environment for several weeks or months in favorable conditions of moderate heat and moisture. The aim of the present study was to georeference, for the first time, the locations of Eimeria occurrences in Mexico from 1961 to 2018. A dataset was created for 3414 reports of Eimeria occurrences in cattle, sheep, and goats in Mexico. Twelve species of Eimeria that infect cattle were recorded, 11 Eimeria species of sheep are present in Mexico, and eight species of goats are geographically distributed in the country. In the current findings, it has been observed that Eimeria colonizes mainly the temperate semihumid, temperate humid, warm humid, and warm semihumid areas during spring and summer in animals younger than 1 year of age. Macroenvironmental variables like temperature and rainfall influence the prevalence of Eimeria in cattle, sheep, and goats, and for some species, the rearing system, facility type, farm size, and altitude affect the occurrence of this parasite. Results may support future studies aimed at reducing the disease prevalence of the parasite in endemic regions of Mexico. The use of recorded cases and climate variables yields a more comprehensive perspective of the epidemiology of eimeriosis, which would be difficult to infer from laboratory studies alone.


Asunto(s)
Enfermedades de los Bovinos/parasitología , Coccidiosis/veterinaria , Eimeria/aislamiento & purificación , Enfermedades de las Ovejas/parasitología , Animales , Bovinos , Enfermedades de los Bovinos/epidemiología , Clima , Coccidiosis/epidemiología , Coccidiosis/parasitología , Eimeria/clasificación , Cabras , México/epidemiología , Estaciones del Año , Ovinos , Enfermedades de las Ovejas/epidemiología
10.
Vet Parasitol ; 260: 38-44, 2018 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-30197011

RESUMEN

The effective dose of an injectable prodrug, named compound alpha prodrug, against immature and adult Fasciola hepatica in experimentally infected sheep was determined. In a first experiment, 30 sheep were infected with Fasciola hepatica on day 0 and 50. After microscopic detection of faecal eggs on day 80, groups (n = 6) 1 to 3 were treated with 6, 8 and 10 mg/kg of the experimental water-soluble prodrug compound alpha intramuscularly, respectively. Group 4 was treated with closantel and group 5 remained untreated. Copromicroscopical examinations were made on day 0, 80 and 108. On day 110, trematodes were collected from the bile ducts. Fasciolicide efficacy was assessed as a percentage of fluke-egg and adult-fluke reduction. Fluke length was also recorded. In a second experiment aimed to assess the fasciolicide activity of compound alpha prodrug against four-week-old flukes, 12 sheep were infected on day 0 and allocated into two groups (n = 6). On day 50 post infection, group A was treated with the experimental water-soluble prodrug compound alpha at 6 mg/kg/IM and B remained untreated. Fasciolicide activity was assessed on day 80 after collection, microscopic observation and measurement of flukes present in the parenchyma for immature stages and on day 108 for adults. Egg output decreased 91.2, 96.0, 98.8 and 94.9% for groups 1, 2, 3 and 4, respectively. Compound alpha prodrug cleared 97.6%, 98.51% and 100% of adult stages in a dose-dependent manner. Closantel killed 81.95% flukes. Regarding the second experiment, 81.2% efficacy was achieved. Immature flukes were significantly smaller in the treated group. It is concluded that the intramuscular application of compound alpha prodrug exerted fasciolicide efficacy against adults of Fasciola hepatica.


Asunto(s)
Antihelmínticos/uso terapéutico , Composición de Medicamentos/veterinaria , Fasciola hepatica/efectos de los fármacos , Fascioliasis/veterinaria , Profármacos/uso terapéutico , Enfermedades de las Ovejas/tratamiento farmacológico , Animales , Antihelmínticos/administración & dosificación , Antihelmínticos/química , Antihelmínticos/aislamiento & purificación , Fascioliasis/tratamiento farmacológico , Fascioliasis/parasitología , Heces/parasitología , Inyecciones Intramusculares , Recuento de Huevos de Parásitos , Profármacos/administración & dosificación , Profármacos/efectos adversos , Profármacos/química , Ovinos , Enfermedades de las Ovejas/parasitología , Solubilidad
11.
Geospat Health ; 13(1): 624, 2018 05 07.
Artículo en Inglés | MEDLINE | ID: mdl-29772883

RESUMEN

The tick genus Ripicephalus (Boophilus), particularly R. microplus, is one of the most important ectoparasites that affects livestock health and considered an epidemiological risk because it causes significant economic losses due, mainly, to restrictions in the export of infested animals to several countries. Its spatial distribution has been tied to environmental factors, mainly warm temperatures and high relative humidity. In this work, we integrated a dataset consisting of 5843 records of Rhipicephalus spp., in Mexico covering close to 50 years to know which environmental variables mostly influence this ticks' distribution. Occurrences were georeferenced using the software DIVA-GIS and the potential current distribution was modelled using the maximum entropy method (Maxent). The algorithm generated a map of high predictive capability (Area under the curve = 0.942), providing the various contribution and permutation importance of the tested variables. Precipitation seasonality, particularly in March, and isothermality were found to be the most significant climate variables in determining the probability of spatial distribution of Rhipicephalus spp. in Mexico (15.7%, 36.0% and 11.1%, respectively). Our findings demonstrate that Rhipicephalus has colonized Mexico widely, including areas characterized by different types of climate. We conclude that the Maxent distribution model using Rhipicephalus records and a set of environmental variables can predict the extent of the tick range in this country, information that should support the development of integrated control strategies.


Asunto(s)
Rhipicephalus , Análisis Espacial , Infestaciones por Garrapatas/epidemiología , Animales , Bovinos , Enfermedades de los Bovinos/parasitología , Conjuntos de Datos como Asunto , México/epidemiología
12.
Front Vet Sci ; 5: 333, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30687723

RESUMEN

Besnoitia besnoiti is the causative agent of bovine besnoitiosis. B. besnoiti infections lead to reduced fertility and productivity in cattle causing high economic losses, not only in Europe, but also in Asia and Africa. Mild to severe clinical signs, such as anasarca, oedema, orchitis, hyperkeratosis, and characteristic skin and mucosal cysts, are due to B. besnoiti tachyzoite and bradyzoite replication in intermediate host tissues. So far, there are no commercially available effective drugs against this parasite. Curcumin, a polyphenolic compound from Curcuma longa rhizome is well-known for its antioxidant, anti-inflammatory, immunomodulatory and also anti-protozoan effects. Hence, the objective of this study was to evaluate the effects of curcumin on viability, motility, invasive capacity, and proliferation of B. besnoiti tachyzoites replicating in primary bovine umbilical vein endothelial cells (BUVEC) in vitro. Functional inhibition assays revealed that curcumin treatments reduce tachyzoite viability and induce lethal effects in up to 57% of tachyzoites (IC50 in 5.93 µM). Referring to general motility, significant dose-dependent effects of curcumin treatments were observed. Interestingly, curcumin treatments only dampened helical gliding and twirling activities whilst longitudinal gliding motility was not significantly affected. In addition, curcumin pretreatments of tachyzoites resulted in a dose-dependent reduction of host cell invasion as detected by infections rates at 1 day p. i. These findings demonstrate feeding cattle with Curcuma longa rhizomes may represent a new strategy for besnoitiosis treatment.

13.
Parasit Vectors ; 10(1): 52, 2017 01 31.
Artículo en Inglés | MEDLINE | ID: mdl-28143543

RESUMEN

BACKGROUND: Giardia parasites cause gastrointestinal disease in humans, dogs, and many other animals worldwide. The treatment of dogs for giardiasis requires further investigation to ascertain levels of drug efficacy and the possibility of adverse side effects. Nitazoxanide (NTZ) has shown good clinical anti-Giardia activity in humans, yet it has not been evaluated for the treatment of giardiasis in dogs. METHODS: Thirty-five dogs, naturally infected with Giardia were divided into five groups (n = 7): dogs in group NTZ1, NTZ2, and NTZ3 were treated with a single oral dose of 37.5 mg/kg, 75 mg/kg, and 150 mg/kg, respectively, of NTZ on days 0 and 14. The fourth group was treated with a commercially available regimen that includes a combination of pyrantel, praziquantel, and febantel (FEB) administered orally for three consecutive days. Additionally, an untreated control group was established. Giardia cysts from the stool of each dog were quantified on days -3, 0, 5, 7, 9, 11, 14, 18, 25, and 28. Biochemical parameters were evaluated in all dogs, before the first treatment and after concluding the experiment. RESULTS: Shedding of Giardia cysts was reduced in all treated groups when compared to untreated controls (P < 0.01). However, NTZ2, NTZ3, and FEB had a lower risk during the study. Furthermore, NTZ was also effective against another protozoan, Cryptosporidium spp. at doses of 75 mg/kg and 150 mg/kg, in contrast to the combination of febantel + pyrantel + praziquantel. Biochemical parameters of treated animals, namely, aspartate transaminase and alanine transaminase enzymes, remained within physiological ranges. CONCLUSIONS: Based on these results, the implementation of NTZ as a treatment for giardiasis in dogs is proposed. The administration of a single dose is an important advantage of NTZ because it reduces workload, particularly in animals placed in shelters and kennels, where handling of large numbers of animals is required, and personnel is frequently scarce.


Asunto(s)
Antiprotozoarios/uso terapéutico , Enfermedades de los Perros/tratamiento farmacológico , Giardiasis/veterinaria , Tiazoles/efectos adversos , Tiazoles/uso terapéutico , Administración Oral , Alanina Transaminasa/sangre , Animales , Antiprotozoarios/administración & dosificación , Antiprotozoarios/efectos adversos , Aspartato Aminotransferasas/sangre , Criptosporidiosis/tratamiento farmacológico , Cryptosporidium/efectos de los fármacos , Enfermedades de los Perros/parasitología , Perros , Heces/parasitología , Giardia/efectos de los fármacos , Giardia/aislamiento & purificación , Giardia/fisiología , Giardiasis/tratamiento farmacológico , Giardiasis/parasitología , Guanidinas/administración & dosificación , Guanidinas/efectos adversos , Guanidinas/uso terapéutico , Humanos , Nitrocompuestos , Praziquantel/administración & dosificación , Praziquantel/efectos adversos , Praziquantel/uso terapéutico , Pamoato de Pirantel/administración & dosificación , Pamoato de Pirantel/efectos adversos , Pamoato de Pirantel/uso terapéutico , Tiazoles/administración & dosificación
14.
Vet Parasitol ; 232: 58-65, 2016 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-27890083

RESUMEN

The current study aimed to determine the anti-Eimeria efficacy of an extract of grapefruit peels (GF) and commercial naringenin (NAR) in naturally-infected lambs, as well as the influence of these flavonoids on the oxidative status during ovine coccidiosis. Pharmacokinetic profiles were also determined. Extracts were administered per os to Eimeria naturally infected growing lambs during 90 consecutive days. The commercial anticoccidial drug toltrazuril (TTZ) was included in this trial as a standard. Twenty-four lambs were divided into four groups: NAR, lambs given a daily dose of 5mg of a commercial naringenin extract of 98% higher purity per kg body weight; GF, lambs that recived a daily dose of 5mg of ethanolic extract of grapefruit peels per kg body weight; TTZ, lambs treated with 20mg of toltrazuril/kg body weight on days 0 and 15 of the experiment; and CTRL, untreated lambs that received daily dose of 30ml of water. Daily doses of GF and NAR were dissolved in 30ml of water and orally given to animals; whereas toltrazuril was administered as a single dose of an undiluted suspension to lambs of the TTZ group. The CTRL group received 30ml of water; as well as the TTZ group for the period after the single dose administration. Fecal and serum samples were collected from all lambs. Anticoccidial efficacy was estimated by coprological techniques. Generation of nitric oxide levels and the antioxidant capacity of the experimental compounds were determined by the Griess and ABTS assays, respectively. The pharmacokinetic parameters of NAR and the GF extract were obtained. On day 30 post-ingestion, anticoccidial efficacy was 91.76% (NAR) and 89.65% (GF); whereas 99.63% of efficacy was achieved with TTZ 15days after treatment. NAR, GF and TTZ significantly reduced oxidative stress in infected animals. The mean daily weight gain for each group was 122g (NAR), 122g (GF), 143g (TTZ) and 98g (CTRL). Following the oral administration of NAR and GF, values in plasma approached maximum concentrations within 2.1 to 2.5h. In conclusion, the administration of NAR and the GF extract reduced Eimeria oocyst output, oxidative stress and promoted higher mean daily weight gains in infected lambs.


Asunto(s)
Citrus paradisi/química , Coccidiosis/veterinaria , Flavanonas/uso terapéutico , Extractos Vegetales/uso terapéutico , Enfermedades de las Ovejas/tratamiento farmacológico , Animales , Coccidiosis/tratamiento farmacológico , Coccidiostáticos/farmacología , Coccidiostáticos/uso terapéutico , Eimeria , Femenino , Flavanonas/farmacología , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Ovinos , Resultado del Tratamiento , Triazinas/farmacología , Triazinas/uso terapéutico , Aumento de Peso/efectos de los fármacos
15.
Bioorg Med Chem Lett ; 24(14): 3069-72, 2014 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-24878192

RESUMEN

A family of 15 N-substituted phenothiazines was designed, synthesized and their acaricidal activity against Rhipicephalus microplus was determined in vitro. The synthetic methodology is simple and can be employed in multigram scale. The rationale for the structure-based design of these compounds is the potential for azines and phenothiazine to engage in π-π interactions; these fragments, joined together by a short, flexible alkoxide linker, structurally resemble phenothiazine-based cholinesterase inhibitors, while their weak basicity implies a neutral active form, rather than a cationic one, thus facilitating penetration of the cuticle of ticks. One compound displayed excellent acaricidal activity (LD50=0.58 µg/mL). Preliminary SAR analysis suggests that the activity is influenced by the presence of a weakly basic nitrogen atom, as well as the substitution pattern within the heterocycles.


Asunto(s)
Diseño de Fármacos , Fenotiazinas/farmacología , Rhipicephalus/efectos de los fármacos , Control de Ácaros y Garrapatas , Animales , Relación Dosis-Respuesta a Droga , Estructura Molecular , Fenotiazinas/síntesis química , Fenotiazinas/química , Relación Estructura-Actividad
16.
Ann N Y Acad Sci ; 1149: 183-5, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19120206

RESUMEN

The aim of the present study was to evaluate the fasciolicide activity of three experimental drugs, selected by an in silico system called TOMOCOMD-CARDD, in sheep. Drugs were identified by the computer system, and, after statistical selection, 24 Pelibuey sheep were infected on days 0 and 30, each with 200 metacercariae of Fasciola hepatica. When the infection reached 8 and 4 weeks of age, respectively, four groups of six animals each were formed. Group 1 received thiacetazone 150 mg/animal/p.o. Group 2 was treated with 3,5,5, trimethyloxazolidine 2,4-dione at 450 mg/animal/p.o. G3 received guanabenz acetate at a dose of 1.5 mg/animal/p.o. G4 served as an untreated control. Monitoring of the animals was followed by individual coprological examinations and slaughter of the animals 15 days after treatment to collect and count flukes from the liver. Efficacy was measured as the reduction in the percentage of flukes of treated animals relative to untreated controls. Results indicated an efficacy of 80.0, 43.8, and 100% for 8-week-old flukes and 62.1, 57.9, and 100% for 4-week-old flukes in the three experimental groups, respectively. Even though guanabenz acetate showed a high efficacy, it was highly toxic since two animals died approximately 24 h after being treated. We conclude that further investigations should be conducted to perform computer-aided prediction of drugs aimed to detect fasciolicide activity.


Asunto(s)
Antihelmínticos/farmacología , Fasciola hepatica/efectos de los fármacos , Guanabenzo/farmacología , Oxazoles/farmacología , Ovinos/parasitología , Tioacetazona/farmacología , Animales
17.
Parasitol Res ; 100(3): 461-5, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17024356

RESUMEN

Fasciola hepatica secretes proteolytic enzymes during liver invasion. The present study examined the effects of the cysteine protease inhibitor Ep-475 on sheep considering the following variables: serum levels of aspartate aminotransferase, L-lactate dehydrogenase, and gamma-glutamyltransferase, liver fluke fecundity, egg viability, parasite burden, and size. Twenty-four male sheep were randomly allocated in four groups of six animals each as follows: group A was infected with F. hepatica metacercariae and treated with 50 mg/kg of Ep-475, group B was infected and untreated, group C was uninfected and treated, and group D was uninfected and untreated. All animals were euthanized 10 weeks after the experimental infection. Serum activities of enzymes in infected animals were significantly lower in Ep-475-treated sheep than in untreated controls, although liver damage was produced. No significant reduction in total worm burden was observed between treated and untreated sheep. However, there was a significant difference on the average size, structure development, ova counts, and egg viability of liver flukes from these two groups. Results showed that Ep-475 reduces liver damage due to fasciolosis and induces an impairment of liver fluke growth and fecundity. These effects pinpoint liver fluke proteases as potential targets for pharmacological intervention.


Asunto(s)
Inhibidores de Cisteína Proteinasa/farmacología , Fasciola hepatica/efectos de los fármacos , Fascioliasis/veterinaria , Fertilidad/efectos de los fármacos , Leucina/análogos & derivados , Óvulo/efectos de los fármacos , Enfermedades de las Ovejas/parasitología , Animales , Inhibidores de Cisteína Proteinasa/uso terapéutico , Fasciola hepatica/enzimología , Fasciola hepatica/fisiología , Fascioliasis/tratamiento farmacológico , Fascioliasis/parasitología , Leucina/farmacología , Leucina/uso terapéutico , Ovinos , Enfermedades de las Ovejas/tratamiento farmacológico
18.
Parasitol Res ; 98(5): 438-42, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16397759

RESUMEN

Using the film in situ zymography (FIZ) technique, it has been demonstrated that N-[N-(L: -3-trans-carboxyoxirane-2-carbonyl)-L: -leucyl]-agmatine (E-64) inhibits Fasciola hepatica proteolytic activity in vivo. The aim of this study was to establish the dose-response relationship of the inhibition of proteolysis as assessed by FIZ with E-64 at different dosages in a murine model of fasciolosis. Maximum effective inhibition of proteolysis was achieved at 50 mg/kg/day (87%). Mice treated with this dose survived for a mean of 10.92 days more than untreated controls, and their ova counts and egg viability were significantly (P<0.05) lower than this latter group. These results indicate that intraperitoneal administration of E-64 not only inhibited liver proteolytic activity in a dose-dependent manner but also produced anti-fecundity and anti-embryonation effects, delaying the progression of fasciolosis. Yet, residual proteolysis may suggest that other E-64-non-sensitive enzymes are involved, or that E-64-enzyme chemical interactions are only capable of a partial agonistic-like effect.


Asunto(s)
Cisteína Endopeptidasas/metabolismo , Inhibidores de Cisteína Proteinasa/farmacología , Fasciola hepatica/efectos de los fármacos , Fascioliasis/tratamiento farmacológico , Leucina/análogos & derivados , Animales , Supervivencia Celular , Inhibidores de Cisteína Proteinasa/administración & dosificación , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Fasciola hepatica/enzimología , Fascioliasis/parasitología , Fertilidad , Inyecciones Intraperitoneales , Leucina/administración & dosificación , Leucina/farmacología , Hígado/parasitología , Ratones , Recuento de Huevos de Parásitos , Análisis de Supervivencia
19.
Parasitol Res ; 96(5): 308-11, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15918068

RESUMEN

Fasciola hepatica secretes cysteine proteases that play a role in facilitating parasite migration. The aim of this study was to detect the inhibition of the proteolytic activity of F. hepatica cysteine proteases in the liver of C57BL/6 cathepsin B knockout mice (cat B-/-) and wild-type controls (cat B+/+) by intraperitoneal administration of N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl]-agmatine, (E-64) using the film in situ zymography (FIZ) technique and image analysis. The FIZ technique revealed that intraperitoneal administration of E-64 dramatically reduced (85%) F. hepatica proteolytic activity in the liver of experimentally infected mice with no discernable side effects. These results suggest the usefulness of the FIZ for determining in vivo activity of F. hepatica proteases, as well as their inhibition by intraperitoneal administration of E-64 in hepatic tissue of infected mice.


Asunto(s)
Catepsina B/deficiencia , Cisteína Endopeptidasas/metabolismo , Fasciola hepatica/enzimología , Hígado/metabolismo , Animales , Catepsina B/genética , Catepsinas/antagonistas & inhibidores , Pruebas Enzimáticas Clínicas/métodos , Fasciola hepatica/fisiología , Fascioliasis/metabolismo , Gelatina/metabolismo , Inyecciones Intraperitoneales , Leucina/administración & dosificación , Leucina/análogos & derivados , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...